Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs

por Komen, Joris, Forslund, Tomas, Hjemdahl, Paul, Wettermark, Björn
Publicado 2017

Valproic acid utilization among girls and women in Stockholm: Impact of regulatory restrictions

por Karlsson Lind, Linnéa, Komen, Joris, Wettermark, Björn, von Euler, Mia, Tomson, Torbjörn
Publicado 2018

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

por Eriksson, Irene, Komen, Joris, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Publicado 2018

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study

por Rustem Gulluoglu, Fatma, Souverein, Patrick C., van den Ham, Hendrika A., de Boer, Anthonius, Komen, Joris
Publicado 2020

Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk

por Komen, Joris J, Heerdink, Eibert R, Klungel, Olaf H, Mantel-Teeuwisse, Aukje K, Forslund, Tomas, Wettermark, Björn, Hjemdahl, Paul
Publicado 2020

Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study

por Komen, Joris J., Belitser, Svetlana V., Wyss, Richard, Schneeweiss, Sebastian, Taams, Anne C., Pajouheshnia, Romin, Forslund, Tomas, Klungel, Olaf H.
Publicado 2021

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality

por Komen, Joris J, Forslund, Tomas, Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, von Euler, Mia, Braunschweig, Frieder, Wallén, Håkan, Hjemdahl, Paul
Publicado 2019

Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021

por Komen, Joris J, Forslund, Tomas, Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, von Euler, Mia, Braunschweig, Frieder, Wallén, Håkan, Hjemdahl, Paul
Publicado 2021

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds

por Komen, Joris, Pottegård, Anton, Hjemdahl, Paul, Mantel-Teeuwisse, Aukje K, Wettermark, Björn, Hellfritzsch, Maja, Hallas, J, Herings, Ron, Smits, Lisa, Forslund, Thomas, Klungel, Olaf
Publicado 2022

Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study( )

por Komen, Joris J, Pottegård, Anton, Mantel-Teeuwisse, Aukje K, Forslund, Tomas, Hjemdahl, Paul, Wettermark, Björn, Hallas, Jesper, Olesen, Morten, Bennie, Marion, Mueller, Tanja, Carragher, Raymond, Karlstad, Øystein, Kjerpeseth, Lars J, Klungel, Olaf H
Publicado 2022

Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries

por Komen, Joris J, Pottegård, Anton, Mantel-Teeuwisse, Aukje K, Forslund, Tomas, Hjemdahl, Paul, Wettermark, Björn, Hellfritzsch, Maja, Hallas, Jesper, Olesen, Morten, Bennie, Marion, Mueller, Tanja, Voss, Annemarie, Schink, Tania, Haug, Ulrike, Kollhorst, Bianca, Karlstad, Øystein, Kjerpeseth, Lars J, Klungel, Olaf H
Publicado 2021